Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma

Keyphrases

• Osteosarcoma 100%
• Array Comparative Genomic Hybridization (aCGH) 100%
• Genome-wide Microarray 100%
• Comparative Genomic Hybridization Analysis 100%
• Necrosis 50%
• Homozygous Deletion 50%
• Gene Copy number Variation 50%
• Fluorescence in Situ Hybridization 50%
• High-level Amplifications 50%
• 17p11.2 50%
• High-resolution 25%
• Chemotherapy 25%
• Screening Method 25%
• Molecular Genetics 25%
• Older Adults 25%
• Tumor Progression 25%
• Genetic Screening 25%
• High Risk 25%
• Therapeutic Target 25%
• Human Genome 25%
• Primary Tumor 25%
• Genetic Events 25%
• Poor Outcome 25%
• Tumor Initiation 25%
• Diagnostic Targets 25%
• Chromosomal Amplification 25%
• Relapse Risk 25%
• Potential Identification 25%
• Genome Database 25%
• Complex Karyotype 25%
• Gross Total Resection 25%
• SOX1 25%
• 8q24 25%
• Definitive Surgery 25%
• Peripheral Myelin Protein 22 (PMP22) 25%
• Histological Response 25%
• Amplicon 25%
• Tumor Genome 25%
• PRDM16 25%
• 6p12 25%
• CDC5L 25%
• Metastatic Osteosarcoma 25%
• Bone Neoplasms 25%
• Response Degree 25%
• NFKBIE 25%
• MGRN1 25%

Biochemistry, Genetics and Molecular Biology

• Array Comparative Genomic Hybridization 100%
• Gene Dosage 66%
• Fluorescence in Situ Hybridization 66%
• Karyotype 33%
• Comparative Genomic Hybridization 33%
• Molecular Genetics 33%
• Screening 33%
• Human Genome 33%
• Tumor Initiation 33%
• P21 33%
• Amplicon 33%
• SOX1 33%
• Tumor Progression 33%
• Peripheral Myelin Protein 22 33%